Allergan v. MSN Laboratories: Federal Circuit Places Limits on Obviousness-Type Double Patenting
Written by : Brianne M. Kingery & Michael L. Fuller On August 13, 2024, the Federal Circuit issued its decision in Allergan USA, Inc. v. MSN Laboratories Private Ltd., No. 24-1061, [1] which limits the scope of obviousness-type double patenting for patents…